OXC-201 | m-entrepreneurship.com

Product Name :
OXC-201

Search keywords :
TH5487

drugId :
null

Target Vo:
N-glycosylase/DNA lyase

Target Vo Short Name :
OGG1

Moa_Name:
N-glycosylase/DNA lyase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oxcia AB

Active Company_Name :
Oxcia AB

Active Indication_Name:
Idiopathic Pulmonary Fibrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Chk1 (S296) Rabbit mAb Biological Activity
Batoclimab custom synthesis
Nrf1 Antibody: Nrf1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Nrf1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts